Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | Vepafestinib |
Trade Name | |
Synonyms | TAS0953/HM06 |
Drug Descriptions |
Vepafestinib (TAS0953/HM06) is a selective, ATP-competitive RET inhibitor with activity against RET fusions and V804 and G810 mutants, which may result in decreased tumor cell growth (Mol Cancer Ther 2021;20(12 Suppl):Abstract nr P06-02; Mol Cancer Ther 2021;20(12 Suppl):Abstract nr P233). |
DrugClasses | RET Inhibitor 53 |
CAS Registry Number | NA |
NCIT ID | C176968 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
Vepafestinib | Vepafestinib | 2 | 1 |